Monday, November 17th
8h30-9h00 : Welcome Ceremony – FN Gilly (
9h00-9h30 : Opening Lecture – PH Sugarbaker (
Moving from consensus to clinical integration with the help of intracavitary pharmacology
9h30-11h00: Indications and place of imaging. Role of radiologists.
Chairmen: F Cotton (
9h30-9h50: Cytoreductive surgery and intraperitonel chemotherapy: which peritoneal surface malignancy should be treated ? Recommendations.
P. Piso (
9h50-10h10: What should be expected from imaging before cytoreduction for peritoneal carcinomatosis: the surgeon's point of view.
S. Gonzales Moreno (Madrid, Spain)
10h10-10h30: Imaging and peritoneal carcinomatosis: what should be preoperative exams? The radiologist's point of view.
O. Pellet (
11h00-11h30: Coffee Break and Sponsor / Poster Visiting
11h30-13h00: How to improve patient selection. Role of general surgeons.
Chairmen: V. Verwaal (Amsterdam, Netherland), H. Mahteme (Uppsala, Sweden)
11h30-11h50: Place of laparoscopy for the evaluation of carcinomatosis extent
M. Valle (
11h50-12h10: Recommendations to general surgeons for preoperative peritoneal carcinomatosis discovery
B. Moran (
12h10-12h30: Selection of patients with colorectal carcinomatosis for a procedure combining perioperative intraperitoneal chemotherapy. Proposition of guidelines.
M. Pocard (
13h00-14h30: Lunch and Sponsor / Poster Visiting
14h30-15h45: Cytoreductive surgery. Technical aspects (Video-Photo)
Chairmen: DM Kecmanovic (
14h30-14h45: Pelvic disease. Douglassectomy, Pelviperitonectomy.
D. Elias (
14h45-15h00: Bowel and mesentery disease. Anastomoses, Stomy.
S. O'Dwyer (
15h00-15h15: Parietal disease. Parietal peritonectomy (gutters, cupula), Scar removing
15h15-15h30: Sus-mesocolic disease. Omental bursa, Lesser omentum, Cholecyctectomy and Gastrectomy.
V. Verwaal (
15h45-16h00: BREAK AND SPONSOR / POSTER VISITING
16h00-18h20: Peritoneal Surface Malignancy. A multidisciplinary approach. Role of Anesthesiologists, Nutritionists, Nurses, Perfusionists.
Chairmen: KH Link (
16h00-16h20: A Belgian experience of starting carcinomatosis program
A. Kartheuser (
16h20-16h40: Treatment of postoperative surgical complications
A. Gomez Portilla (Vitoria, Spain)
16h40-17h00: Nutrition and quality of life following cytoreductive procedures
RP McQuellon (Winston
17h00-17h20: Hyperthermic intraperitoneal chemotherapy: does the anesthesiological strategy differ from other extensive abdominal strategies ?
V. Billard (
17h20-17h40: Intraoperative parameters that could be markers of morbidity
S. Kusamura (
17h40-18h00: Nurses implications in perioperative management of patients treated by cytoreductive surgery and intraperitoneal chemotherapy
S. Alves (
18h30-19h00: "Rendez-vous" in front of ENS for bus.
19h30: COCKTAIL IN
Tuesday, November 18th
8h30-10h00: Colorectal Cancers
Chairmen: F. Antos (
8h30-8h50: Cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal carcinomatosis. Results of the French multicentric database.
D. Elias (
8h50-9h10: French ongoing trials in the treatment of peritoneal carcinomatosis from colorectal cancer
F. Quenet (
J. Esquivel (
9h30-9h50: Long term of randomized study in colorectal carcinomatosis
V. Verwaal (
10h00-10h30: Coffee Break and Sponsor / Poster Visiting
10h30-12h40: Rare Peritoneal Surface Malignancies and Place of Pathologist
Chairmen: B. Moran (
10h30-10h50: Cytoreductive surgery and perioperative intraperitoneal chemotherapy for rare peritoneal disease. Results of the French multicentric database.
O. Glehen (
10h50-11h10: The renewal of pseudomyxoma peritonei pathology
S. Bruin (
11h10-11h30: New prognostics factors for peritoneal mesotheliome
M. Deraco (
11h30-11h50: French National Organization for the treatment of rare peritoneal disease:RENAPE. From a national to an international cooperation.
FN Gilly (
11h50-12h10: Multi-institutional prospective data registery for peritoneal mesotheliome
TD Yan (
12h40-14h30: Lunch and Sponsor / Poster Visiting
14h30-15h45: Gastric Cancer
Chairmen : P. Shen (Winston
14h30-14h50: Place of hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis from gastric cancer. Results of French multicentric database.
C. Arvieux (
14h50-15h10: Neoadjuvant intrapertoneal chemotherapy in advanced gastric cancer.
Y. Yonemura (
15h10-15h30: Prevention of peritoneal carcinomatosis in gastric cancer.
A. Garofalo (
15h45-17h30: Hyperthermic Intraperitoneal Chemotherapy: Unusual Indications.
Chairmen: D. Elias (
15h45-16h05: Second look for patients at risk of peritoneal carcinomatosis and place of prophylactic hyperthermic intraperitoneal chemotherapy.
H. Mahteme (
16h05-16h25: Place of hyperthermic intraperitoneal chemotherapy as palliative treatment (ascitis)
S. Miska (
16h35-17h00: BREAK AND SPONSOR / POSTER VISITING
17h00-17h10: HIPEC feasible by everybody: the hotwire revolution.Video-session.
Patrick Rat (
17h10-17h20: Early experience with cytoreductive surgery and continuous hyperthermic peritoneal perfusion (CHPP) in children.
Andrea Hayes-Jordan (Houston, USA)
17h20-17h30: Thoracic cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy for pseudomyxoma peritonei.
Terence C. Chua (
17h30-18h45: FREE PAPER SESSION n°1
Chairmen: S. Gonzales
20h30: DINER DE GALA
Casino Lyon Vert – La Tour de Salvagny
Wednesday, November 19th
8h30-10h30: Pharmacokinetics and Biological Session
Chairmen: F. Mohamed (
8h30-8h45: Pharmacokinetics of intraperitoneal cisplatinium
E. Cotte (
8h45-9h00: Effect of intraperitoneal pressure and adrenalin in pharmacokinetics of intraperitoneal drugs
B. Chauffert (
9h00-9h20: Key points on pharmacokinetics of intraperitoneal chemotherapy
E. de Bruijn (Leuven, Belgium)
9h20-9h40: New targeted therapy: Application for loco-regional therapy
JF Pingpank (
9h40-10h00: Chemotherapy, environmental and juridic aspects.
AC Sayag-Beaujard (Lyon, Frace)
10h30-11h00: Coffee Break and Sponsor / Poster Visiting
11h00-12h00: FREE PAPER SESSION n°2
13h30-15h30: Ovarian Cancer
Chairmen: G. Freyer (
13h30-13h50: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian cancer. French experience.
JM Bereder (Nice,
13h50-14h10: Place of hyperthermic intraperitoneal chemotherapy in ovarian cancer. The surgeon's point of view.
W. Helm (
14h10-14h30: Place of hyperthermic intraperitoneal chemotherapy in ovarian cancer. The medical oncologist's point of view.
I. Ray Coquard (
14h30-14h40: Perspectives in clinical research for the treatment of peritoneal carcinomatosis in ovarian cancer
M. Deraco (
By decision of the French Education and Research Ministry.